Activation of the Met kinase confers acquired drug resistance in FGFR-targeted lung cancer therapy
Oncogenesis 5, e241 (July 2016). doi:10.1038/oncsis.2016.48
Authors: S-M Kim, H Kim, M R Yun, H N Kang, K-H Pyo, H J Park, J M Lee, H M Choi, P Ellinghaus, M Ocker, S Paik, H R Kim & B C Cho
from Cancer via ola Kala on Inoreader http://ift.tt/29PV7Dl
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου